Atlas Trials

Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome

Clinical trial NCT01329770 · COMPLETED

Trial details

NCT number
NCT01329770
Sponsor
Yolanda de Diego Otero
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fragile X Syndrome
Start date
2010-12-01
Primary completion
2015-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.